跳至主要内容
临床试验/NCT03112122
NCT03112122终止4 期

Randomized, Double-blind Study for the Treatment of the Bone Marrow Edema:Core Decompression Versus (VS) Subchondral Injections of Autologous BMC VS Subchondral Injections of Bone Substitute

Istituto Ortopedico Rizzoli1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年3月11日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
入组人数
1
试验地点
1
主要终点
change of Visual Analogue Scale (VAS) score

研究概览

简要总结

Randomized, controlled, three-arm, double-blind study : control group, treated with core decompression technique VS subchondral plasty by injecting i-FactorTM VS injections of autologous BMC.

详细描述

The clinical trial is a randomized, controlled, three-arm, double-blind study, involving up to 120 patients. Eligible subjects will be randomly allocated to one of the three treatment groups: control group, treated with core decompression technique, study group 1, treated with subchondral plasty by injecting i-FactorTM, and study group 2, treated by injections of autologous BMC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female patients between 18 and 75 years;
  • •Symptomatic subchondral bone marrow lesions of femoral condyles (grade ≥ 1 according to the WORMS MRI score);
  • •Failure after at least two months of a conservative treatment;
  • •Single BME areas involving a single compartment of the knee;
  • •Availability of the patients to participate actively in the rehabilitation protocol and follow-up clinic and radiology;
  • •Signature of informed consent.

排除标准

  • •Patients incapable of discernment;
  • •History of allergy to calcium phosphates;
  • •Patients with malignancies;
  • •Patients with rheumatic diseases;
  • •Patients with diabetes;
  • •Patients suffering of metabolic disorders of the thyroid;
  • •Patients with history of abuse of alcohol, drugs or medication;
  • •Patients with advanced osteoarthritis (Kellgren-Lawrence grade> 3);
  • •Body Mass Index> 35;
  • •BME that involve more than one compartment;
  • •Patients with trauma in the 6 months prior to the intervention. -

研究组 & 干预措施

core decompression technique

Active Comparator

The standard surgical technique is the subchondral anterograde drilling, which permit a revascularization of the Bone Marrow Edema (BME) and a reduction of the intramedullary pressure (core decompression).

干预措施: core decompression (Procedure)

bone substitution (i-FactorTM)

Experimental

i-FactorTM is a combination of the mineral component of bone (Anorganic Bone Mineral) with a peptide replicating the cell-binding domain of Type-I collagen (P-15). It has been used in bone defects and in spine fusion providing good clinical results. Thus, i-FactorTM could be a valid and efficient bone substitute to treat BMLs with subchondral injections.

干预措施: bone substitute i-FactorTM (Biological)

injections of autologous Bone Marrow Concentrate (BMC)

Experimental

injections of autologous BMC.

干预措施: autologous bone marrow concentrate (Biological)

结局指标

主要结局

change of Visual Analogue Scale (VAS) score

时间窗: [Timepoint: Screening, 1 , 3 6, 12, 24 months]

improvement in VAS score from baseline to follow up

次要结局

  • Knee Injury and Osteoarthritis Outcome (KOOS) Score([Timepoint: Screening, 1 , 3 6, 12, 24 months])
  • Tegner Activity Level Scale([Timepoint: Screening, 1 , 3 6, 12, 24 months])
  • International Knee Documentation Committee (IKDC) subjective score([Timepoint: Screening, 1 , 3 6, 12, 24 months])

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Federica Balboni

Sub-Investigator

Istituto Ortopedico Rizzoli

研究点 (1)

Loading locations...

相似试验